New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H 2 synthases
dc.contributor.author | Aronoff, David M. | en_US |
dc.contributor.author | Oates, John A. | en_US |
dc.contributor.author | Boutaud, Olivier | en_US |
dc.date.accessioned | 2015-01-07T15:24:18Z | |
dc.date.available | 2015-01-07T15:24:18Z | |
dc.date.issued | 2006-01 | en_US |
dc.identifier.citation | Aronoff, David M.; Oates, John A.; Boutaud, Olivier (2006). "New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H 2 synthases." Clinical Pharmacology & Therapeutics 79(1): 9-19. | en_US |
dc.identifier.issn | 0009-9236 | en_US |
dc.identifier.issn | 1532-6535 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/109994 | |
dc.publisher | Taylor & Francis | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.title | New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H 2 synthases | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/109994/1/cptclpt20062.pdf | |
dc.identifier.doi | 10.1016/j.clpt.2005.09.009 | en_US |
dc.identifier.source | Clinical Pharmacology & Therapeutics | en_US |
dc.identifier.citedreference | Simmons, D. L., Botting, R. M., Robertson, P. M., Madsen, M. L. and Vane, J. R. ( 1999 ). Induction of an acetaminophen‐sensitive cyclooxygenase with reduced sensitivity to nonsteroid antiinflammatory drugs. Proc Natl Acad Sci U S A 96: 3275 – 3280. | en_US |
dc.identifier.citedreference | Chandrasekharan, N. V., Dai, H., Roos, K. L., Evanson, N. K., Tomsik, J. and Elton, T. S. et al. ( 2002 ). COX‐3, a cyclooxygenase‐1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A 99: 13926 – 13931. | en_US |
dc.identifier.citedreference | Davies, N. M., Good, R. L., Roupe, K. A. and Yanez, J. A. ( 2004 ). Cyclooxygenase‐3: axiom, dogma, anomaly, enigma or splice error?—Not as easy as 1, 2, 3. J Pharm Pharm Sci 7: 217 – 226. | en_US |
dc.identifier.citedreference | Snipes, J. A., Kis, B., Shelness, G. S., Hewett, J. A. and Busija, D. W. ( 2005 ). Cloning and characterization of cyclooxygenase‐1b (putative cyclooxygenase‐3) in rat. J Pharmacol Exp Ther 313: 668 – 676. | en_US |
dc.identifier.citedreference | Dinchuk, J. E., Liu, R. Q. and Trzaskos, J. M. ( 2003 ). COX‐3: in the wrong frame in mind [letter]. Immunol Lett 86: 121. | en_US |
dc.identifier.citedreference | Shaftel, S. S., Olschowka, J. A., Hurley, S. D., Moore, A. H. and O'Banion, M. K. ( 2003 ). COX‐3: a splice variant of cyclooxygenase‐1 in mouse neural tissue and cells. Brain Res Mol Brain Res 119: 213 – 215. | en_US |
dc.identifier.citedreference | Prescott, L. F. ( 1996 ). Paracetamol (acetaminophen): a critical bibliographic review. Taylor & Francis: Bristol (UK), 67 – 102. Chap. 6 | en_US |
dc.identifier.citedreference | Carpenter, H. M. and Mudge, G. H. ( 1981 ). Acetaminophen nephrotoxicity: studies on renal acetylation and deacetylation. J Pharmacol Exp Ther 218: 161 – 167. | en_US |
dc.identifier.citedreference | Nicholls, A. W., Caddick, S., Wilson, I. D., Farrant, R. D., Lindon, J. C. and Nicholson, J. K. ( 1995 ). High resolution NMR spectroscopic studies on the metabolism and futile deacetylation of 4‐hydroxyacetanilide (paracetamol) in the rat. Biochem Pharmacol 49: 1155 – 1164. | en_US |
dc.identifier.citedreference | Mattammal, M. B., Zenser, T. V., Brown, W. W., Herman, C. A. and Davis, B. B. ( 1979 ). Mechanism of inhibition of renal prostaglandin production by acetaminophen. J Pharmacol Exp Ther 210: 405 – 409. | en_US |
dc.identifier.citedreference | Newton, R., Kuitert, L. M., Bergmann, M., Adcock, I. M. and Barnes, P. J. ( 1997 ). Evidence for involvement of NFkappaB in the transcriptional control of COX‐2 gene expression by IL‐1beta. Biochem Biophys Res Commun 237: 28 – 32. | en_US |
dc.identifier.citedreference | von Bruchhausen, F. and Baumann, J. ( 1982 ). Inhibitory actions of desacetylation products of phenacetin and paracetamol on prostaglandin synthetases in neuronal and glial cell lines and rat renal medulla. Life Sci 30: 1783 – 1791. | en_US |
dc.identifier.citedreference | Hogestatt, E. D., Jonsson, B. A., Ermund, A., Andersson, D. A., Bjork, H. and Alexander, J. P. et al. ( 2005 ). Conversion of acetaminophen to the bioactive N‐acyl phenolamine AM404 via fatty acid amide hydrolase‐dependent arachidonic acid conjugation in the nervous system. J Biol Chem 280: 31405 – 31412. | en_US |
dc.identifier.citedreference | Guhring, H., Hamza, M., Sergejeva, M., Ates, M., Kotalla, C. E. and Ledent, C. et al. ( 2002 ). A role for endocannabinoids in indomethacin‐induced spinal antinociception. Eur J Pharmacol 454: 153 – 163. | en_US |
dc.identifier.citedreference | Aronoff, D. M., Boutaud, O., Marnett, L. J. and Oates, J. A. ( 2003 ). Inhibition of prostaglandin H2 synthases by salicylate is dependent on the oxidative state of the enzymes. J Pharmacol Exp Ther 304: 589 – 595. | en_US |
dc.identifier.citedreference | Boutaud, O., Brame, C. J., Salomon, R. G., Roberts, L. J. and Oates, J. A. ( 1999 ). Characterization of the lysyl adducts formed from prostaglandin H2 via the levuglandin pathway. Biochemistry 38: 9389 – 9396. | en_US |
dc.identifier.citedreference | Qin, N., Zhang, S. P., Reitz, T. L., Mei, J. M. and Flores, C. M. ( 2005 ). Cloning, expression, and functional characterization of human cyclooxygenase‐1 splicing variants: evidence for intron 1 retention. J Pharmacol Exp Ther 315: 1298 – 1305.E‐pub 2005 Sep 1. | en_US |
dc.identifier.citedreference | Funk, C. D. ( 2001 ). Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294: 1871 – 1875. | en_US |
dc.identifier.citedreference | Aronoff, D. M. and Neilson, E. G. ( 2001 ). Antipyretics: mechanisms of action and clinical use in fever suppression. Am J Med 111: 304 – 315. | en_US |
dc.identifier.citedreference | Catella‐Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S. and Tournier, B. et al. ( 2001 ). Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 345: 1809 – 1817. | en_US |
dc.identifier.citedreference | Lages, B. and Weiss, H. J. ( 1989 ). Inhibition of human platelet function in vitro and ex vivo by acetaminophen. Thromb Res 53: 603 – 613. | en_US |
dc.identifier.citedreference | Dubois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S. and Van De Putte, L. B. et al. ( 1998 ). Cyclooxygenase in biology and disease. FASEB J 12: 1063 – 1073. | en_US |
dc.identifier.citedreference | Boutaud, O., Aronoff, D. M., Richardson, J. H., Marnett, L. J. and Oates, J. A. ( 2002 ). Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H2 synthases. Proc Natl Acad Sci U S A 99: 7130 – 7135. | en_US |
dc.identifier.citedreference | Feldberg, W., Gupta, K. P., Milton, A. S. and Wendlandt, S. ( 1973 ). Effect of pyrogen and antipyretics on prostaglandin activity in cisternal c.s.f. of unanaesthetized cats. J Physiol 234: 279 – 303. | en_US |
dc.identifier.citedreference | Muth‐Selbach, U. S., Tegeder, I., Brune, K. and Geisslinger, G. ( 1999 ). Acetaminophen inhibits spinal prostaglandin E2 release after peripheral noxious stimulation. Anesthesiology 91: 231 – 239. | en_US |
dc.identifier.citedreference | Green, K., Drvota, V. and Vesterqvist, O. ( 1989 ). Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). Prostaglandins 37: 311 – 315. | en_US |
dc.identifier.citedreference | Seppala, E., Nissila, M., Isomaki, H., Wuorela, H. and Vapaatalo, H. ( 1990 ). Effects of non‐steroidal antiinflammatory drugs and prednisolone on synovial fluid white cells, prostaglandin E2, leukotriene B4 and cyclic AMP in patients with rheumatoid arthritis. Scand J Rheumatol 19: 71 – 75. | en_US |
dc.identifier.citedreference | Hinsberg, O. and Kast, A. ( 1887 ). Ueber die Wirkung des Acetphenetidins. Zentralbl Med Wiss 25: 145 – 148. | en_US |
dc.identifier.citedreference | von Mering, J. ( 1893 ). Beiträge zur Kenntniss der Antipyretica. Ther Mon 7: 577 – 587. | en_US |
dc.identifier.citedreference | Clissold, S. P. ( 1986 ). Paracetamol and phenacetin. Drugs 32: 46 – 59. | en_US |
dc.identifier.citedreference | Brodie, B. B. and Axelrod, J. ( 1949 ). The fate of acetophenetidin (phenacetin) in man and methods for the estimation of acetophenetidin and its metabolites in biological material. J Pharmacol Exp Ther 97: 58 – 67. | en_US |
dc.identifier.citedreference | Feldberg, W. and Gupta, K. P. ( 1972 ). Sampling for biological assay of cerebrospinal fluid from the third ventricle in the unanaesthetized cat. J Physiol 222: 126P – 129P. | en_US |
dc.identifier.citedreference | Ohki, S., Ogino, N., Yamamoto, S. and Hayaishi, O. ( 1979 ). Prostaglandin hydroperoxidase, an integral part of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J Biol Chem 254: 829 – 836. | en_US |
dc.identifier.citedreference | Harvison, P. J., Egan, R. W., Gale, P. H. and Nelson, S. D. ( 1986 ). Acetaminophen as a cosubstrate and inhibitor of prostaglandin H synthase. Adv Exp Med Biol 197: 739 – 747. | en_US |
dc.identifier.citedreference | Markey, C. M., Alward, A., Weller, P. E. and Marnett, L. J. ( 1987 ). Quantitative studies of hydroperoxide reduction by prostaglandin H synthase. Reducing substrate specificity and the relationship of peroxidase to cyclooxygenase activities. J Biol Chem 262: 6266 – 6279. | en_US |
dc.identifier.citedreference | Tsai, A. and Kulmacz, R. J. ( 2000 ). Tyrosyl radicals in prostaglandin H synthase‐1 and ‐2. Prostaglandins Other Lipid Mediat 62: 231 – 254. | en_US |
dc.identifier.citedreference | Rouzer, C. A. and Marnett, L. J. ( 2003 ). Mechanism of free radical oxygenation of polyunsaturated fatty acids by cyclooxygenases. Chem Rev 103: 2239 – 2304. | en_US |
dc.identifier.citedreference | Ouellet, M. and Percival, M. D. ( 2001 ). Mechanism of acetaminophen inhibition of cyclooxygenase isoforms. Arch Biochem Biophys 387: 273 – 280. | en_US |
dc.identifier.citedreference | Boyd, J. A. and Eling, T. E. ( 1981 ). Prostaglandin endoperoxide synthetase‐dependent cooxidation of acetaminophen to intermediates which covalently bind in vitro to rabbit renal medullary microsomes. J Pharmacol Exp Ther 219: 659 – 664. | en_US |
dc.identifier.citedreference | Harvison, P. J., Egan, R. W., Gale, P. H., Christian, G. D., Hill, B. S. and Nelson, S. S. ( 1988 ). Acetaminophen and analogs as cosubstrates and inhibitors of prostaglandin H synthase. Chem Biol Interact 64: 251 – 266. | en_US |
dc.identifier.citedreference | Moldeus, P., Andersson, B., Rahimtula, A. and Berggren, M. ( 1982 ). Prostaglandin synthetase catalyzed activation of paracetamol. Biochem Pharmacol 31: 1363 – 1368. | en_US |
dc.identifier.citedreference | Moldeus, P. and Rahimtula, A. ( 1980 ). Metabolism of paracetamol to a glutathione conjugate catalyzed by prostaglandin synthetase. Biochem Biophys Res Commun 96: 469 – 475. | en_US |
dc.identifier.citedreference | Potter, D. W. and Hinson, J. A. ( 1987 ). The 1‐and 2‐electron oxidation of acetaminophen catalyzed by prostaglandin H synthase. J Biol Chem 262: 974 – 980. | en_US |
dc.identifier.citedreference | Masferrer, J. L., Zweifel, B. S., Seibert, K. and Needleman, P. ( 1990 ). Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest 86: 1375 – 1379. | en_US |
dc.identifier.citedreference | Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J. and Vane, J. R. ( 1994 ). Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A 90: 11693 – 11697. | en_US |
dc.identifier.citedreference | Riendeau, D., Charleson, S., Cromlish, W., Mancini, J. A., Wong, E. and Guay, J. ( 1997 ). Comparison of the cyclooxygenase‐1 inhibitory properties of nonsteroidal anti‐inflammatory drugs (NSAIDs) and selective COX‐2 inhibitors, using sensitive microsomal and platelet assays. Can J Physiol Pharmacol 75: 1088 – 1095. | en_US |
dc.identifier.citedreference | Hanel, A. M. and Lands, W. E. ( 1982 ). Modification of anti‐inflammatory drug effectiveness by ambient lipid peroxides. Biochem Pharmacol 31: 3307 – 3311. | en_US |
dc.identifier.citedreference | Dietz, R., Nastainczyk, W. and Ruf, H. H. ( 1988 ). Higher oxidation states of prostaglandin H synthase. Rapid electronic spectroscopy detected two spectral intermediates during the peroxidase reaction with prostaglandin G2. Eur J Biochem 171: 321 – 328. | en_US |
dc.identifier.citedreference | Karthein, R., Dietz, R., Nastainczyk, W. and Ruf, H. H. ( 1988 ). Higher oxidation states of prostaglandin H synthase. EPR study of a transient tyrosyl radical in the enzyme during the peroxidase reaction. Eur J Biochem 171: 313 – 320. | en_US |
dc.identifier.citedreference | Cushman, D. W. and Cheung, H. S. ( 1976 ). Effect of substrate concentration on inhibition of prostaglandin synthetase of bull seminal vesicles by anti‐inflammatory drugs and fenamic acid analogs. Biochim Biophys Acta 424: 449 – 459. | en_US |
dc.identifier.citedreference | Kis, B., Snipes, J. A., Simandle, S. A. and Busija, D. W. ( 2005 ). Acetaminophen‐sensitive prostaglandin production in rat cerebral endothelial cells. Am J Physiol Regul Integr Comp Physiol 288: R897 – R902. | en_US |
dc.identifier.citedreference | Cao, C., Matsumura, K., Yamagata, K. and Watanabe, Y. ( 1996 ). Endothelial cells of the rat brain vasculature express cyclooxygenase‐2 mRNA in response to systemic interleukin‐1 beta: a possible site of prostaglandin synthesis responsible for fever. Brain Res 733: 263 – 272. | en_US |
dc.identifier.citedreference | Inoue, W., Matsumura, K., Yamagata, K., Takemiya, T., Shiraki, T. and Kobayashi, S. ( 2002 ). Brain‐specific endothelial induction of prostaglandin E(2) synthesis enzymes and its temporal relation to fever. Neurosci Res 44: 51 – 61. | en_US |
dc.identifier.citedreference | Yamagata, K., Matsumura, K., Inoue, W., Shiraki, T., Suzuki, K. and Yasuda, S. et al. ( 2001 ). Coexpression of microsomal‐type prostaglandin E synthase with cyclooxygenase‐2 in brain endothelial cells of rats during endotoxin‐induced fever. J Neurosci 21: 2669 – 2677. | en_US |
dc.identifier.citedreference | Li, S., Ballou, L. R., Morham, S. G. and Blatteis, C. M. ( 2001 ). Cyclooxygenase‐2 mediates the febrile response of mice to interleukin‐1beta. Brain Res 910: 163 – 173. | en_US |
dc.identifier.citedreference | Li, S., Wang, Y., Matsumura, K., Ballou, L. R., Morham, S. G. and Blatteis, C. M. ( 1999 ). The febrile response to lipopolysaccharide is blocked in cyclooxygenase‐2(‐/‐), but not in cyclooxygenase‐1(‐/‐) mice. Brain Res 825: 86 – 94. | en_US |
dc.identifier.citedreference | Lucas, R., Warner, T. D., Vojnovic, I. and Mitchell, J. A. ( 2005 ). Cellular mechanisms of acetaminophen: role of cyclooxygenase. FASEB J 19: 635 – 637. | en_US |
dc.identifier.citedreference | Johnson, E. N., Brass, L. F. and Funk, C. D. ( 1998 ). Increased platelet sensitivity to ADP in mice lacking platelet‐type 12‐lipoxygenase. Proc Natl Acad Sci U S A 95: 3100 – 3105. | en_US |
dc.identifier.citedreference | Calzada, C., Vericel, E. and Lagarde, M. ( 1997 ). Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo‐oxygenase activation. Biochem J 325: 495 – 500. | en_US |
dc.identifier.citedreference | Fels, A. O., Pawlowski, N. A., Cramer, E. B., King, T. K., Cohn, Z. A. and Scott, W. A. ( 1982 ). Human alveolar macrophages produce leukotriene B4. Proc Natl Acad Sci U S A 79: 7866 – 7870. | en_US |
dc.identifier.citedreference | Martin, T. R., Altman, L. C., Albert, R. K. and Henderson, W. R. ( 1984 ). Leukotriene B4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung. Am Rev Respir Dis 129: 106 – 111. | en_US |
dc.identifier.citedreference | Sun, D. and Funk, C. D. ( 1996 ). Disruption of 12/15‐lipoxygenase expression in peritoneal macrophages. Enhanced utilization of the 5‐lipoxygenase pathway and diminished oxidation of low density lipoprotein. J Biol Chem 271: 24055 – 24062. | en_US |
dc.identifier.citedreference | Mielke, C. H. ( 1981 ). Comparative effects of aspirin and acetaminophen on hemostasis. Arch Intern Med 141: 305 – 310. | en_US |
dc.identifier.citedreference | O'Brien, W. F., Krammer, J., O'Leary, T. D. and Mastrogiannis, D. S. ( 1993 ). The effect of acetaminophen on prostacyclin production in pregnant women. Am J Obstet Gynecol 168: 1164 – 1169. | en_US |
dc.identifier.citedreference | Baumann, J., von Bruchhausen, F. and Wurm, G. ( 1983 ). Inhibition of prostaglandin synthetases derived from neuronal and glial cells and rat renal medulla by ortho‐, meta‐and para‐substituted aminophenolic compounds. Prostaglandins Leukot Med 10: 319 – 329. | en_US |
dc.identifier.citedreference | Botting, R. M. ( 2000 ). Mechanism of action of acetaminophen: is there a cyclooxygenase 3 ?. Clin Infect Dis 31 ( Suppl 5 ): S202 – S210. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.